Skip to main content

Pfizer agrees to settle more than 10K lawsuits over Zantac cancer risk: Bloomberg News

Packages of Zantac are pictured in this 2019 file photo. (AP Photo/Mark Lennihan) Packages of Zantac are pictured in this 2019 file photo. (AP Photo/Mark Lennihan)
Share

Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with the deal.

The agreements cover cases in U.S. state courts but don't completely resolve the company's exposure to Zantac claims, the report said, adding that financial details of the deals were not immediately available.

Pfizer did not immediately respond to a Reuters request for comment.

In 2020, the U.S. Food and Drug Administration asked drugmakers to pull Zantac and its generic versions off the market after a cancer-causing substance called NDMA was found in samples of the drug.

Thousands of lawsuits began piling up in federal and state courts against Pfizer, GSK GSK.L, Sanofi SASY.PA and Boehringer Ingelheim.

CTVNews.ca Top Stories

What women should know about their breasts, according to a doctor

One in eight women will be diagnosed with invasive breast cancer in their lifetimes, according to the American Cancer Society. Breast cancer is the second leading cause of cancer death for women in the United States, with 42,000 women dying every year from this cancer.

Local Spotlight

Video shows meteor streaking across Ontario

Videos of a meteor streaking across the skies of southern Ontario have surfaced and small bits of the outer space rock may have made it to land, one astronomy professor says.